RNS Number : 7452C Spire Healthcare Group PLC 28 March 2025 Spire Healthcare Group plc (the Company) 28 March 2025 Notification of Transactions of Persons Discharging Managerial Responsibilities Grant of Long Term Incentive Plan (LTIP) awards The Company announces that, on 27 March 2025, a performance share award was granted over the Company's ordinary shares in the form of nil cost options to the following Executive Directors in the Company, under the rules of the Company's Long Term Incentive Plan. Executive Director                Maximum number of shares under Award Justin Ash                               759,173 Harbant Samra                       436,681 The number of shares set out above represents 200% of current base salary.  It is the maximum number which may vest under the LTIP Awards following the end of the performance period (31 December 2027).  The shareholder-approved Remuneration Policy permits awards of up to 200% of base salary for Executive Directors. The actual number of shares which vest will depend on the extent to which the relevant performance conditions have been satisfied. The performance conditions applicable to the LTIP Awards will be based as follows: · 20% on relative total shareholder return (TSR) performance; · 35% on ROCE performance; · 15% on Hospital EBIT Margin performance; and · 30% on two Operational Excellence measures. Further details of these performance conditions will be disclosed in the 2024 Annual Report and Accounts when published. The share price used to determine the number of shares under the LTIP Awards was 174.04 pence being the average of the mid-market closing share price over the five trading days ending on 26 March 2025. The transaction place is London. Notes: 1)   For both Executive Directors the 2025 LTIP awards described above will also be subject to a further two-year holding period following the vesting date. 2) The actual number of shares which vest under the LTIP awards will depend on the extent to which the relevant performance conditions are satisfied in due course. Name of contact and telephone number for queries: Philip Davies Head of Secretariat Spire Healthcare Group plc Tel:      07803 508348 Notification and public disclosure of transaction by persons discharging managerial responsibility and persons closely associated with them This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DSHBXGDXIGDDGUI